Role of coronary artery calcium in cardiovascular risk assessment

References

• Naghavi M, Falk E, Hecht HS et al. From vulnerable plaque to vulnerable patient—part III: executive summary of the screening for heart attack prevention and education (SHAPE) task force report. Am. J. Cardiol. 98(2 Suppl. 1), 2–15 (2006).
   Google Scholar
• Blankenhorn DH, Stern D. Calcification of the coronary arteries. Am. J. Roentgenol. Radium Ther. Nucl. Med. 81(5), 772–777 (1959).
   PubMedGoogle Scholar
• Detrano RC, Wong ND, French WJ et al. Prevalence of fluoroscopic coronary calcific deposits in high-risk asymptomatic persons. Am. Heart J. 127(6), 1526–1532 (1994).
   Google Scholar
• Wong ND, Vo A, Abrahamson D, Tobis JM, Eisenberg H, Detrano RC. Detection of coronary artery calcium by ultrafast computed tomography and its relation to clinical evidence of coronary artery disease. Am. J. Cardiol. 73(4), 223–227 (1994).
   Google Scholar
• Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte J, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15(4), 827–832 (1990).
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362(6423), 801–809 (1993).
   PubMed Web of Science ®Google Scholar
• Greenland P, Bonow RO, Brundage BH et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA writing committee to update the 2000 expert consensus document on electron beam computed tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J. Am. Coll. Cardiol. 49(3), 378–402 (2007).
   PubMed Web of Science ®Google Scholar
• Koller MT, Steyerberg EW, Wolbers M et al. Validity of the Framingham point scores in the elderly: Results from the Rotterdam study. Am. Heart J. 154(1), 87–93 (2007).
   Google Scholar
• Nasir K, Rubin J, Shaw LJ et al. Interaction of coronary artery calcification and increasing burden of traditional risk factors on all cause mortality. Circulation 122, A18506 (2010).
   Google Scholar
• Yeboah J, McClelland RL, Polonsky TS et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 308(8), 788–795 (2012).
   PubMed Web of Science ®Google Scholar
• Polonsky TS, McClelland RL, Jorgensen NW et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 303(16), 1610–1616 (2010).
   PubMed Web of Science ®Google Scholar
• Detrano R, Guerci AD, Carr JJ et al. Coronary calcium and events in four ethnic groups. N. Engl. J. Med. 359(2), 202–204 (2008).
   Google Scholar
• Greenland P, Alpert JS, Beller GA et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 122(25), 2748–2764 (2010).
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112(17), 2735–2752 (2005).
   PubMed Web of Science ®Google Scholar
• IDF. IDF Worldwide Definition of the Metabolic Syndrome. IDF, Brussels, Belgium (2006).
   Google Scholar
• Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J. Am. Coll. Cardiol. 49(21), 2112–2119 (2007).
   PubMed Web of Science ®Google Scholar
• Lakka H. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288(21), 2709–2716 (2002).
   PubMed Web of Science ®Google Scholar
• Malik S, Wong ND, Franklin SS et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110(10), 1245–1250 (2004).
   PubMed Web of Science ®Google Scholar
• Muntner P. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III) Ann. Epidemiol. 14(9), 686–695 (2004).
   Web of Science ®Google Scholar
• Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52(5), 1210–1214 (2003).
   PubMed Web of Science ®Google Scholar
• Wong ND, Sciammarella MG, Polk D et al. The metabolic syndrome, diabetes, and subclinicalatherosclerosis assessed by coronary calcium. J. Am. Coll. Cardiol. 41(9), 1547–1553 (2003).
   Google Scholar
• Liu J, Grundy SM, Wang W et al. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am. Heart J. 153(4), 552–558 (2007).
   Google Scholar
• Hunt KJ, Williams K, Hazuda HP, Stern MP, Haffner SM. The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio heart study. Ann. Epidemiol. 17, 870–877 (2007).
   PubMed Web of Science ®Google Scholar
• Malik S, Budoff MJ, Katz R et al. Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes the multi-ethnic study of atherosclerosis. Diabetes Care 34(10), 2285–2290 (2011).
   PubMed Web of Science ®Google Scholar
• Wong ND, Nelson JC, Granston T et al. Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the multiethnic study of atherosclerosis study. JACC Cardiovasc. Imaging 5(4), 358–366 (2012).
   PubMedGoogle Scholar
• Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339(4), 229–234 (1998).
   PubMed Web of Science ®Google Scholar
• Schramm TK, Gislason GH, Køber L et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk a population study of 3.3 million people. Circulation 117(15), 1945–1954 (2008).
   PubMed Web of Science ®Google Scholar
• Evans JMM. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ 324(7343), 939–939 (2002).
   Google Scholar
• Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 368(9529), 29–36 (2006).
   PubMed Web of Science ®Google Scholar
• Di Carli MF, Hachamovitch R. Should we screen for occult coronary artery disease among asymptomatic patients with diabetes? J. Am. Coll. Cardiol. 45(1), 50–53 (2005).
   Google Scholar
• Colhoun HM, Betteridge DJ, Durrington PN et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364(9435), 685–696 (2004).
   PubMed Web of Science ®Google Scholar
• Boden WE, O’Rourke RA, Teo KK et al. Optimal medical therapy with or without PCI for stable coronary disease. N. Engl. J. Med. 356(15), 1503–1516 (2007).
   PubMed Web of Science ®Google Scholar
• [No authors listed]. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10–11 February 1998, Miami, Florida. American Diabetes Association. Diabetes Care 21(9), 1551–1559 (1998).
   Google Scholar
• Bax JJ, Young LH, Frye RL, Bonow RO, Steinberg HO, Barrett EJ. Screening for coronary artery disease in patients with diabetes. Diabetes Care 30(10), 2729–2736 (2007).
   PubMedGoogle Scholar
• Elkeles RS, Godsland IF, Feher MD et al. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study. Eur. Heart J. 29(18), 2244–2251 (2008).
   PubMed Web of Science ®Google Scholar
• Shavelle DM, Budoff MJ, LaMont DH, Shavelle RM, Kennedy JM, Brundage BH. Exercise testing and electron beam computed tomography in the evaluation of coronary artery disease. J. Am. Coll. Cardiol. 36(1), 32–38 (2000).
   Google Scholar
• Kajinami K, Seki H, Takekoshi N, Mabuchi H. Noninvasive prediction of coronary atherosclerosis by quantification of coronary artery calcification using electron beam computed tomography: Comparison with electrocardiographic and thallium exercise stress test results. J. Am. Coll. Cardiol. 26(5), 1209–1221 (1995).
   PubMed Web of Science ®Google Scholar
• O’Rourke RA, Brundage BH, Froelicher VF et al. American College of Cardiology/American Heart Association expert consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J. Am. Coll. Cardiol. 36(1), 326–340 (2000).
   PubMed Web of Science ®Google Scholar
• Rajagopalan N, Miller TD, Hodge DO, Frye RL, Gibbons RJ. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J. Am. Coll. Cardiol. 45(1), 43–49 (2005).
   PubMed Web of Science ®Google Scholar
• Mielke C, Shields J, Broemeling L. Coronary artery calcium, coronary artery disease, and diabetes. Diabetes Res. Clin. Pract. 53(1), 55–61 (2001).
   PubMed Web of Science ®Google Scholar
• Goraya TY, Leibson CL, Palumbo PJ et al. Coronary atherosclerosis in diabetes mellitus. J. Am. Coll. Cardiol. 40(5), 946–953 (2002).
   PubMed Web of Science ®Google Scholar
• Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J. Am. Coll. Cardiol. 43(9), 1663–1669 (2004).
   PubMed Web of Science ®Google Scholar
• Shaw LJ, Min JK, Budoff M et al. Induced cardiovascular procedural costs and resource consumption patterns after coronary artery calcium screening results from the EISNER (early identification of subclinical atherosclerosis by noninvasive imaging research) study. J. Am. Coll. Cardiol. 54(14), 1258–1267 (2009).
   Google Scholar
• Rozanski A, Gransar H, Shaw LJ et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing: the EISNER (early identification of subclinical atherosclerosis by noninvasive imaging research) prospective randomized trial. J. Am. Coll. Cardiol. 57(15), 1622–1632 (2011).
   PubMed Web of Science ®Google Scholar
• Arad Y, Spadaro LA, Roth M, Newstein D, Guerci AD. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. J. Am. Coll. Cardiol. 46(1), 166–172 (2005).
   Google Scholar
• Johnson JE. Risk perception, psychological well-being and health-promoting behaviors in persons informed of a coronary artery calcium score. Dissertations 304 (2012).
   Google Scholar
• van Kempen BJH, Spronk S, Koller MT et al. Comparative effectiveness and cost-effectiveness of computed tomography screening for coronary artery calcium in asymptomatic individuals. J. Am. Coll. Cardiol. 58(16), 1690–1701 (2011).
   PubMed Web of Science ®Google Scholar
• Taylor AJ, Bindeman J, Feuerstein I, Cao F, Brazaitis M, O’Malley PG. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the prospective army coronary calcium (PACC) project. J. Am. Coll. Cardiol. 46(5), 807–814 (2005).
   Web of Science ®Google Scholar
• Budoff MJ, Hokanson JE, Nasir K et al. Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc. Imaging 3(12), 1229–1236 (2010).
   PubMed Web of Science ®Google Scholar
• Budoff MJ, Young R, Lopez VA et al. Progression of coronary calcium and incident coronary heart disease events: the multi-ethnic study of atherosclerosis. J. Am. Coll. Cardiol. 61, 1231–1239 (2013).
   PubMed Web of Science ®Google Scholar
• Raggi P, Davidson M, Callister TQ et al. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic post menopausal women beyond endorsed lipid lowering with EBT scanning (BELLES). Circulation 112(4), 563–571 (2005).
   PubMedGoogle Scholar
• Budoff MJ, Achenbach S, Blumenthal RS et al. Assessment of coronary artery disease by cardiac computed tomography a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 114(16), 1761–1791 (2006).
   PubMed Web of Science ®Google Scholar
• Kennedy J, Shavelle R, Wang S, Budoff M, Detrano RC. Coronary calcium and standard risk factors in symptomatic patients referred for coronary angiography. Am. Heart J. 135(4), 696–702 (1998).
   PubMed Web of Science ®Google Scholar
• Georgiou D, Budoff MJ, Kaufer E, Kennedy JM, Lu B, Brundage BH. Screening patients with chest pain in the emergency department using electron beam tomography: a follow-up study. J. Am. Coll. Cardiol. 38(1), 105–110 (2001).
   PubMed Web of Science ®Google Scholar
• Nabi F, Chang SM, Pratt CM et al. Coronary artery calcium scoring in the emergency department identifying which patients with chest pain can be safely discharged home. Ann. Emerg. Med. 56(3), 220–229 (2010).
   Google Scholar